EW financials
Edwards Lifesciences (EW) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
EW income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $6.07B | $4.74B | $1.64B | $1.07B | 1.83 |
| 2024 | $5.44B | $4.32B | $1.38B | $4.17B | 6.97 |
| 2023 | $5.01B | $3.97B | $1.43B | $1.40B | 2.30 |
| 2022 | $5.38B | $4.22B | $1.70B | $1.52B | 2.44 |
| 2021 | $5.23B | $4.01B | $1.61B | $1.50B | 2.38 |
| 2020 | $4.39B | $3.29B | $1.30B | $823.40M | 1.30 |
- EW revenue was $6.07B in fiscal 2025, net income $1.07B.
Updated 2026-11-02 17:54 UTC